STUDY SEARCH RESULTS

1 study found for your search request:  7684A-002

Pembrolizumab/vibostolimab coformulation (MK-7684A) or pembrolizumab/vibostolimab coformulation plus...
Condition: Metastatic Non Small Cell Lung Cancer
Minimum Age: 18 years, Maximum Age: N/A
Gender: All
Study ID: NCT04725188
Status: Completed
Has Results




Copyright © 2026 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  Consumer Health Data Privacy Policy  Your Privacy Choices   Accessibility  U.S. Corporate Site